RxDoctor Payments Data

Gary Levinson, MD

Psychiatry · Bend, ORNPI 1841228228

Payments from drug & device makers

$263in general payments, 2019–2025

Across 14 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$67
  • Takeda Pharmaceuticals U.S.A., Inc.$56
  • AbbVie$53
  • Daiichi Sankyo Inc.$24
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$15
  • AstraZeneca$14
  • plus $35 from 3 others

What the payments were for

  • Food & beverage$19675%
  • Education$6725%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$263 in reported general payments places this provider in the 80th percentile of 366 psychiatry providers in Oregon.

See all psychiatry providers in Oregon

Medicare billing

Part B allowed, 2024
$28,554
Medicare patients
49
Services billed
203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl13$18,523
Lurasidone Hcl22$2,541
Naltrexone Hcl18$1,667
Atomoxetine Hcl18$1,454
Bupropion XlBupropion Hcl60$1,388
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine32$1,192
Methylphenidate ErMethylphenidate Hcl19$1,146
Duloxetine Hcl45$1,040
Olanzapine55$841
Aripiprazole19$645
Quetiapine Fumarate66$567
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine28$495
Trazodone Hcl55$453
Hydroxyzine Pamoate45$446
Venlafaxine Hcl ErVenlafaxine Hcl25$435

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$53$18,52313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 366 psychiatry providers in Oregon.

Other psychiatry in Bend

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →